Trial intelligence / Profile preview

High-dose Andrographis paniculata extract capsules in mild COVID-19

TCTR20210914001Phase 0Completed

Sponsor
Thai Traditional Medicine Knowledge Fund
Start
Jun 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 0 trial of andrographis paniculata extract in coronavirus disease 2019 (COVID-19), sponsored by Thai Traditional Medicine Knowledge Fund. Started Jun 2020; status: completed.

02

Drugs

andrographis paniculata extract
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on TCTR20210914001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20210914001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call